TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) › RevenueTEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) — RevenueAnnual figures by period end, from SEC filings.2016-12-31: $21.90B2017-12-31: $21.85B2018-12-31: $18.27B2019-12-31: $16.89B2020-12-31: $16.66B2021-12-31: $15.88B2022-12-31: $14.93B2023-12-31: $15.85B2024-12-31: $16.54B2025-12-31: $17.26B$17.26B2016-12-31Revenue (USD)2025-12-31Period endedRevenueChange YoYSource filing2025-12-31$17.26B+4.3%2026-02-03From 2025-01-012024-12-31$16.54B+4.4%2026-02-03From 2024-01-012023-12-31$15.85B+6.2%2026-02-03From 2023-01-012022-12-31$14.93B-6.0%2025-02-05From 2022-01-012021-12-31$15.88B-4.7%2024-02-12From 2021-01-012020-12-31$16.66B-1.4%2023-02-10From 2020-01-012019-12-31$16.89B-7.6%2022-02-09From 2019-01-012018-12-31$18.27B-16.4%2021-02-10From 2018-01-012017-12-31$21.85B-0.2%2020-02-21From 2017-01-012016-12-31$21.90B—2019-02-19From 2016-01-07Other metrics: Cost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)